NCT00290407 2018-05-04Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)University of LouisvillePhase 2 Terminated2 enrolled 2 charts